Loading…
Viking Therapeutics, Inc. is projected to rise to $56.81 by 2027, a +46% move from its current price of $38.86. VKTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $37.55 | $38.90 | $40.29 | +0.09% |
| Jul 15 | $37.04 | $38.93 | $40.92 | +0.19% |
| Jul 16 | $36.66 | $38.97 | $41.42 | +0.28% |
| Jul 17 | $36.35 | $39.00 | $41.86 | +0.37% |
| Jul 18 | $36.08 | $39.04 | $42.25 | +0.47% |
| Jul 19 | $35.84 | $39.08 | $42.61 | +0.56% |
| Jul 20 | $35.63 | $39.11 | $42.94 | +0.65% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $35.63 | $39.11 | $42.94 | +0.65% |
| Week 2 | $34.50 | $39.37 | $44.93 | +1.31% |
| Week 3 | $33.71 | $39.63 | $46.58 | +1.97% |
| Week 4 | $33.09 | $39.89 | $48.07 | +2.64% |
| Week 5 | $32.58 | $40.15 | $49.47 | +3.31% |
| Week 6 | $32.15 | $40.41 | $50.79 | +3.98% |
| Week 7 | $31.77 | $40.67 | $52.07 | +4.66% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.
Its lead drug VK2809 is an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company also develops VK5211, VK0612, VK2735 and VK0214 for other metabolic and endocrine disorders.
The company was incorporated in 2012 and is headquartered in San Diego, California.
Viking Therapeutics, Inc. (VKTX) is currently trading at $39.08 per share with a market cap of $4.54B and a market rank of 1434.
The stock’s near-term technical picture shows a bullish tilt with a current price framework that sits above notable moving averages. The RSI14 sits at 60, while the stock trades above the 50-day and 200-day moving averages (SMA50 at $32.58 and SMA200 at $33.31).
Forecasts imply a pronounced upside path over the coming years, beginning with a 2026 average price of $39.08 and extending toward a 2050 average of $393.79. The implied returns rise through the horizon, with a 2030 average of $71.27 and a long-run trajectory culminating in substantial gains by 2050.
A major floor 43.7% below — a decisive break under it would weaken the trend.
The nearest floor, 28.6% below — buyers have tended to step in here.
The nearest ceiling, 8.4% above — a clean break opens room to run.
A major ceiling 30.3% above — clearing it would confirm fresh momentum.
Key VKTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VKTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $40.16 | Sell | $39.68 | Sell |
| MA 10 | $39.23 | Sell | $38.71 | Buy |
| MA 20 | $35.58 | Buy | $36.63 | Buy |
| MA 50 | $32.58 | Buy | $34.15 | Buy |
| MA 100 | $33.05 | Buy | $33.33 | Buy |
| MA 200 | $33.31 | Buy | $33.23 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.34 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 54.38 | Neutral |
| Williams %R (14) | -33.50 | Info |
| MACD (12,26,9) | 0.37 | Buy |
| ROC (12) | 11.63 | Buy |
| Bollinger %B (20,2) | 0.68 | Neutral |
| Stochastic %K (14) | 66.50 | Neutral |
| TRIX (15) | 0.94 | Buy |
| Awesome (5,34) | 6.78 | Buy |
| Ultimate (7,14,28) | 56.13 | Neutral |
| Momentum (10) | 1.87 | Buy |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 41.00 | Sell |
| ADX (14) | 27.74 | Buy |
| ATR (14) | 1.31 | Info |
The 30-day technical picture points to a bullish bias, with positive momentum supported by an RSI of 60. Prices are above both the 50-day and 200-day moving averages (SMA50 at $32.58, SMA200 at $33.31), suggesting ongoing drift higher in the near term.
The stock trades within a 30-day range of $30.97 to $49.32, signaling a defined path for near-term action. Key support sits at $27.75 while resistance is near $42.13, shaping a constructive but contained short-term zone.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $26.29 | $38.86 | $60.79 | 0% | Neutral | |
| $44.01 | $56.81 | $78.28 | +46% | Bullish | |
| $47.83 | $64.09 | $92.46 | +65% | Bullish | |
| $49.22 | $68.04 | $101.72 | +75% | Bullish | |
| $49.97 | $71.01 | $109.38 | +83% | Bullish | |
| $55.01 | $80.19 | $126.74 | +106% | Bullish | |
| $60.94 | $90.98 | $147.16 | +134% | Bullish | |
| $74.17 | $113.25 | $187.03 | +191% | Bullish | |
| $83.06 | $129.58 | $218.13 | +233% | Bullish | |
| $86.13 | $137.18 | $235.05 | +253% | Bullish | |
| $120.49 | $211.14 | $389.38 | +443% | Bullish | |
| $187.86 | $390.74 | $800.90 | +906% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $26.29 | $38.86 | $46.50 | +0.00% |
| August 2026 | $34.10 | $40.55 | $49.73 | +4.34% |
| September 2026 | $35.25 | $42.30 | $52.62 | +4.33% |
| October 2026 | $34.99 | $42.32 | $53.29 | +0.06% |
| November 2026 | $35.95 | $43.78 | $55.67 | +3.44% |
| December 2026 | $38.66 | $47.37 | $60.79 | +8.20% |
Click any year to see its month-by-month VKTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, VKTX could reach as high as $60.79, with a base case around $38.86 and support toward $26.29 — roughly 0% from $38.86. Price action looks broadly range-bound.
Expect VKTX to range from $44.01 to $78.28 through 2027. The $56.81 average target implies a +46% move from current prices. That is up +46% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The VKTX price prediction for 2028 points to an average of $64.09 (low $47.83, high $92.46) — a potential gain of +65% on today's $38.86. Momentum favours further upside here.
In 2029, VKTX is projected to trade between $49.22 and $101.72, averaging $68.04 — a potential gain of +75% from today's $38.86. That is up +6% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Viking Therapeutics, Inc.'s 2030 outlook centres on $71.01, within a $49.97 to $109.38 range. That is up +4% on the projected 2029 average. That marks a +83% change versus current levels. Momentum favours further upside here.
By 2031, VKTX could reach as high as $126.74, with a base case around $80.19 and support toward $55.01 — roughly +106% from $38.86. Buyers look set to stay in control over this stretch.
Expect VKTX to range from $60.94 to $147.16 through 2032. The $90.98 average target implies a +134% move from current prices. That is up +13% on the projected 2031 average. Momentum favours further upside here.
The VKTX price prediction for 2033 points to an average of $113.25 (low $74.17, high $187.03) — a potential gain of +191% on today's $38.86. Buyers look set to stay in control over this stretch.
In 2034, VKTX is projected to trade between $83.06 and $218.13, averaging $129.58 — a potential gain of +233% from today's $38.86. That is up +14% on the projected 2033 average. Momentum favours further upside here.
Viking Therapeutics, Inc.'s 2035 outlook centres on $137.18, within a $86.13 to $235.05 range. That is up +6% on the projected 2034 average. That marks a +253% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, VKTX could reach as high as $389.38, with a base case around $211.14 and support toward $120.49 — roughly +443% from $38.86. Momentum favours further upside here.
Expect VKTX to range from $187.86 to $800.90 through 2050. The $390.74 average target implies a +906% move from current prices. That is up +85% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in VKTX today (≈ 25.733402 VKTX) could be worth
$10,055.14
+$9,055.14 (+906%) by 2050 · US Dollar
Based on the average projected VKTX price of $390.74 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VKTXwould be worth at today's price.
$1,000 invested in VKTX on Jul 10, 2025 (≈ 31.959091 VKTX) would be worth
$1,241.93
+$241.93 (+24.2%) today · 1.24× · US Dollar
Based on a VKTX entry price of $31.29 vs. today's $38.86.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $37.44 | $1,037.93 | +3.8% |
| 1 month ago | $27.75 | $1,400.36 | +40.0% |
| 3 months ago | $34.26 | $1,134.27 | +13.4% |
| 6 months ago | $31.76 | $1,223.55 | +22.4% |
| 1 year ago | $31.29 | $1,241.93 | +24.2% |
| All time (5.0y) ago | $5.87 | $6,620.1 | +562.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VKTX forecast.
Our base-case forecast reaches $78.00 around 2031.
Implied market cap at $78.00: $9.06B
The multi-year forecast shows a progressive rise in average prices across most years. The 2026 forecast lists an average price of $39.08 with a 0 ROI and neutral sentiment.
By 2027 the average is projected at $57.04 with a 46 ROI and bullish sentiment; 2028 at $64.47 (65 ROI); 2029 at $68.58 (75.5 ROI); and 2030 at $71.27 (82.4 ROI). The forecast continues to climb through 2031 ($80.79, 106.7 ROI), 2032 ($91.69, 134.6 ROI), 2033 ($113.65, 190.8 ROI), 2034 ($130.67, 234.4 ROI), and 2035 ($138.13, 253.5 ROI) with bullish sentiment.
In the longer horizon, 2040 shows an average of $212.65 (444.1 ROI) and $392.20 as the max; 2050 carries an average of $393.79 (907.6 ROI) with a max of $807.17 and bullish sentiment. These figures are estimates and are not guarantees, reflecting the forecast’s best judgment of price trajectories under varying conditions.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $71.27, a min of $50.14, a max of $109.78, and a ROI of 82.4, with bullish sentiment.
The forecast shows a path from a 2026 average of $39.08 (ROI 0, neutral) to higher averages with bullish sentiment in most years through 2050, but these are estimates and not guarantees.
Yes. The 2030 max is $109.78, indicating the possibility of breaking the $100 level within the forecast horizon.
The 2040 forecast lists an average price of $212.65, with a min of $121.34, a max of $392.20, and a ROI of 444.1, with bullish sentiment.
The 2050 forecast lists an average price of $393.79, a min of $189.30, a max of $807.17, and a ROI of 907.6, with bullish sentiment.
Viking Therapeutics, Inc. Community Discussion
0Share your Viking Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.